18-21-9　ⓔ文献

  1. Frazier AE, Thorburn DR, et al: Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology. J Biol Chem, 2019; 14: 5386–5395.

  2. Sallevelt SCEH, de Die–Smulders EM, et al: De novo mtDNA point mutations are common and have a low recurrence risk. J Med Genet, 2017; 54: 114–124.

  3. Gorman GS, Schaefer AM, et al: Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol, 2015; 77: 753–759.

  4. Sakuta R, Nonaka I: Vascular involvement in mitochondrial myopathy. Ann Neurol, 1989; 25: 594–601.

  5. Goto Y, Horai S, et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke–like episodes (MELAS): a coorelative study of the clinical features and mitochodrial DNA mutation. Neurology, 1992; 42: 542–550.

  6. Kadowaki T, Kadowaki H, et al: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. NEJM, 1994; 330: 962–968.

  7. Ohsawa Y, Hagiwara H, et al: Taurine supplementation for prevention of stroke–like episodes in MELAS: a multicentre, open–label, 52–week phase III trial. J Neurol Neurosurg Psychiatry, 2019; 90: 529–536.